Skip to main content
. 2020 Aug 24;11(8):629–643. doi: 10.5306/wjco.v11.i8.629

Figure 1.

Figure 1

Challenges of non-tumour-related factors during the treatment of high-risk neuroblastoma in low- and middle-income countries. ASCT: Autologous stem-cell transplant; HIC: High-income country; CRA: Cis-retinoic acid.